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Biofunctionalization of Metallic Materials:
Creation of Biosis–Abiosis Intelligent
Interface
Takao Hanawa
Abstract Osseointegration, the first concept of biosis–abiosis intelligent interface,
is primarily explained, and researches on the elucidation of osseointegration mech-
anism and titanium-tissue interface observation are reviewed to understand a
concept to create biosis–abiosis intelligent interface. In addition, current status of
surface treatment of metallic materials is reviewed. In particular, a gap between
research level progress and commercialization in surface treatments is focused.
Mechanical property, durability, and manufacturing process of surface layer formed
on titanium by surface treatment, are significant to commercialize the treatment,
while most of researches focuses only evaluation of biocompatibility and
biofunction.
Keywords Bone formation • Mechanical anchoring • Osseointegration • Surface
treatment • Titanium
5.1 Introduction
Excellent biocompatibility and biofunction of ceramics and polymers are expected
to show excellent properties as biomaterials; in fact many devices consisting of
metals have been substituted by those consisting of ceramics and polymers. In spite
of this event, over 70 % of implant devices in medical field including dentistry,
especially over 95 % in orthopedics, still consist of metals, and this share is
currently maintained, because of their high strength, toughness, and durability.
On the contrary, a disadvantage of using metals as biomaterials is that they are
typically artificial materials and have no biofunction. Therefore, metal surface
naturally forms a clear interface against living tissue that works as a barrier to
conduct biofunctions. To add biocompatibility and biofunction to metals, in other
words, to create biosis–abiosis intelligent interface, surface treatment is essential,
T. Hanawa (*)
Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University,
2-3-10 Kanda-surugadai, Chiyoda-ku, Tokyo 101-0062, Japan
e-mail: hanawa.met@tmd.ac.jp
© The Author(s) 2015
K. Sasaki et al. (eds.), Interface Oral Health Science 2014,
DOI 10.1007/978-4-431-55192-8_5
53
because biofunction cannot be added during manufacturing processes of metals
such as melting, casting, forging, and heat treatment. Surface treatment is a process
that changes a material’s surface composition, structure, and morphology, leaving
the bulk mechanical properties intact.
This chapter primarily reviews past researches on the interface between titanium
and tissue and change in the research trend with era that much help us to understand
a concept to create biosis–abiosis intelligent interface. In addition, current status of
surface treatment of metallic materials is reviewed to enhance new and superior
designs of biosis–abiosis intelligent interface.
5.2 Biosis–Abiosis Intelligent Interface
When a metallic material is implanted into a human body, immediate reaction
occurs between its surface and the living tissues. In other words, immediate reaction
at this initial stage straightaway determines and defines a metallic material’s tissue
compatibility. An artificial material usually makes clear interface against a biolog-
ical system, such as cell, bacterial and tissue: The interface works as a barrier for
transportation of molecules and conduction of biofunction, as shown in Fig. 5.1a.
On the other hand, if we could create unclear and graded interface at which
molecules smoothly transport, both material and tissue are integrated together,
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intelligent interface, as shown in Fig. 5.1b. In addition, this interface is expected to
be a field not only for chemically biofunctional conduction, but also for mechan-
ically stress conduction. If so, how to make this biosis–abiosis intelligent interface?
Of course, one of the solutions is surface treatment of materials. With surface
treatment, tissue compatibility of surface layer could be improved.
5.3 Osseointegration of Titanium
Osseointegration is the first definition of the interface between ametallicmaterial and
living tissue. The definition of osseointegration is as follows: The formation of a
direct interface between an implant and bone, without intervening soft tissue. No scar
tissue, cartilage or ligament fibers are present between the bone and implant surface.
The direct contact of bone and implant surface can be verified microscopically [1].
This “osseointegration” concept was immediately accepted by dentists and dental
materials researchers in the world to show biocompatible advantage of titanium
among metals that makes it possible that titanium occupies major position in dental
implant bodies. After percolating the concept of osseointegration, the elucidation of
osseointegration mechanism including the investigation on microscopic interface
structure between titanium and bone tissue has been actively studied.
5.4 Mechanism of Osseointegration in Titanium
From the viewpoint of the property of titanium surface, mechanism and process of
osseointegration has been discussed. Titanium and some of its alloys are known to be
among the best biocompatible materials, and commercially the materials have been
successfully used for orthopedic and dental implants. The question is why titanium
and its alloys show such good biocompatibility compared with other alloys. The
explanation to the question is generally believed to be that titanium passivates in
aqueous solutions and that passive film is stable even in a biological system.
Therefore, it was first thought that good hard tissue compatibility of titanium is
caused by its high corrosion resistance. This hypothesis was false. For example,
electric plating of platinum on titanium makes delay bone formation on itself, while
the corrosion resistance increased [2]. Therefore, good hard tissue compatibility of
titanium is caused not only by its high corrosion resistance but also other causes.
In this regard, the surface layer of titanium is essentially TiO2 before and after
autoclaving and anodic oxidation treatment [3, 4]. However, it is questionable
whether titanium oxide is stable and does not react with any electrolyte even in
biological system. In this question, themechanisms of passive dissolution of titanium
in a model physiological environment were revealed [5]. They explained that disso-
lution of titanium depends on solution ligands and the surface oxide characteristics.
They also revealed preferential molecular adsorption on titanium [6].
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Composition of surface oxide film varies according to environmental changes,
though the film is macroscopically stable. Passive surfaces co-exist in close contact
with electrolytes, undergoing a continuous process of partial dissolution and
re-precipitation from the microscopic viewpoint. In this sense, surface composition
is always changing according to the environment (Fig. 5.2). The composition and
properties of the oxide film regenerated in a biological environment may be
different from those in water. When titanium which has been surgically implanted
into the human jaw is characterized using Auger electron spectroscopy, its surface
oxide film reveals constituents of calcium, phosphorus, and sulfur [7, 8]. By
immersing titanium and its alloys in Hanks’ solution and other solutions [9–12]
(Fig. 5.3), preferential adsorption of phosphate ions occurs. Even during cell culture
on titanium, calcium phosphate is formed on it [13]. Extrapolating from here, it can
be assumed that bone formation is faster on titanium implanted in hard tissue
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on titanium is not completely oxidized and is relatively reactive; neither calcium
nor phosphate stably exists alone on titanium, and calcium phosphate is naturally
formed on it; calcium phosphate formed on titanium is stable and protective [14].
Surface oxide films as passive films on valve metals such as Ti are almost amor-
phous and different from titanium oxide bulk and crystalline ceramics with regard
to its chemical property.
The surface oxide is always formed on conventional metallic biomaterials and
the surface of the surface oxide is active. Therefore, the oxide surface immediately
reacts with water molecules and hydroxyl groups are formed as shown in Fig. 5.4a.
The surface hydroxyl groups contain both terminal OH and bridge OH in the equal
amounts. Concentration of hydroxyl groups on the unit area of the surface is
determined with various techniques. Active surface hydroxyl groups dissociates
in aqueous solutions and forms electric charges as shown in Fig. 5.4b [15–18].
Positive or negative charge due to the dissociation is governed by pH of the
surrounding aqueous solution: positive and negative charges are balanced and
apparent charge is zero at a certain pH. This pH is the point of zero charge (pzc).
The pzc is the unique value for an oxide and an indicator which the oxide shows
acidic or basic property. For example, in the case of TiO2, the pzc of rutile is 5.3 and
that of anatase is 6.2 [15] (Fig. 5.4c). In other words, anatase surface is acidic at
smaller pH and basic at larger pH than 6.2. Active surface hydroxyl groups and
electric charges formed by the dissociation of the groups play important roles for
the bonding with polymers and immobilization of biomolecules. Therefore, the
Fig. 5.4 Formation of surface hydroxyl groups on titanium oxide by the adsorption of water
molecules (a), dissociation of hydroxyl groups in aqueous solutions including body fluid and
showing positive and negative charges according to the environmental pH (b), and point of zero
charge (pzc) of various oxide (c)
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concentration of surface hydroxyl group and pH is important factors for the bonding
with polymeric materials and immobilization of biomolecules.
Proteins adsorption influences cells adhesion. Likewise, proteins denaturaliza-
tion and fragmentation (which occur due to adsorption) may affect the function of
the host body. To characterize proteins adsorbed to metals and metal oxides,
various techniques can be used [19], especially that of ellipsometry [20]. To
predict proteins adsorption, the wettability test is used where a liquid droplet is
applied to the material [21]. Fibrinogen is much more naturally adsorbed on
titanium surface than on gold surface, because the dielectric constant, the factor
governing electrostatic force, of TiO2 is 80.1 and similar to that of water
[22]. Therefore, fibrinogen remains its conformation even after the adsorption
on titanium surface.
As described above, many researchers made their effort to elucidate the mech-
anism of osseointegration by characterization of titanium surface oxide (composi-
tion and change of it), surface hydroxyl groups, adsorption of proteins (amount,
speed, change in the conformation, and denaturalization), and adhesion, prolifera-
tion and differentiation of cells. However, the true mechanism of osseointegration
is still not clear.
5.5 Nanometer-Level Interface Structure
On the other hand, micrometer and nanometer-level observation of the interface
between titanium and tissue has been studied. The intact bone-to-titanium interface
consists of a fibrous tissue-free boundary zone with a 20–40 nm thick proteoglycan
coat immediately adjacent to titanium oxide are revealed [23, 24]. Bundles of
collagen appear at a minimum distance of 100–200 nm from the interface. Calcium
deposits were sometimes seen in direct contacted (resolution level 30–50 nm) with
the titanium oxide. The similar variation in interface ultrastructure within
50–100 nm of titanium surface [25]. The collagen fibrils did not reach the implant
surface but were separated from it by an amorphous layer, being 300–500 nm thick
which did not decrease in width with time [26]. An electron-dense lamina limitans-
like line containing mineral was observed between the amorphous layer and the bone
tissue. On the other hand, amorphous proteoglycan layer is not interposed at the
interface between bone and titanium was observed [27]. In addition, this lamina
limitans seems to consist of osteopontin and α2 HS-glycoprotein [28]. Recently,
osteoblast-like cells made direct contact with titanium via a 20–50 nm thin amor-
phous zone is shown [29]. A 20–50 nm thin amorphous zone, a slender cell layer,
and/or a poorly mineralized zone were interposed between bone and titanium. There
is apparently a 20–50 nm amorphous layer containing proteoglycan on titanium
oxide according to the above studies. Relatively high-resolutional observation using
transmission electron microscopy is feasible in the findings regarding structure of
the interface. However, it is difficult to make a tissue specimen with metallic
material for TEM observation. Therefore, a couple of studies [24, 25] employed a
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foil and sputter-coated film of titanium instead of bulk material to be easily sectioned
with a microtome. That is, the structure at the interface near titanium is unclear,
while the observation of the interface is currently continued [30].
5.6 Surface Treatment
5.6.1 Change of Research Trend
The above researches on the elucidation of osseointegration mechanism and char-
acterization of structure at the interface, now showed down and research trend
moved to surface treatment for bone formation on titanium. Tremendous amount of
surface treatment researches has been conducted, while some of the researches are
left important matters behind somewhere. In these researches, the control is usually
untreated titanium. Therefore, some researchers declare that “titanium is bioinert”
to demonstrate the effective results of their surface treatment. Origin of this
misunderstanding is that no apatite forms on titanium by SEM-level after immer-
sion in Kokubo’s simulated body fluid (SBF) [31, 32]. Where has the initial
definition of “osseointegration” of titanium gone? The true story is as follows:
Titanium shows the best bone conduction among metallic materials, while the
ability is much lower than bioactive ceramics.
5.6.2 Surface Treatment
Surface treatment is a process that changes a material’s surface composition,
structure, and morphology, leaving the bulk mechanical properties intact. With
surface treatment, the tissue compatibility of the surface layer can be improved, as
shown in Fig. 5.5. Surface treatment techniques by both dry and wet processes used
in research and industry are summarized in Fig. 5.6. Surface treatment techniques
are reviewed elsewhere [33, 34].
5.6.3 Surface Treatment for Bone Formation
Titanium and its alloys, which show good hard tissue compatibility, are used for
dental implants and artificial hip joints. However, the hard-tissue compatibility of
these materials is lower than that of bioactive ceramics, such as hydroxyapatite and
bioactive glasses. Therefore, numerous surface treatment techniques to improve the
hard tissue compatibility of titanium have been developed, and some have been
commercialized.
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Properties required to surface of materials
Bone formation; Bone bonding
Inhibition of bone formation
Adhesion to soft tissue
Blood compatibility

















Fig. 5.5 Category of surface treatment of metallic materials to add biocompatibility and
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Fig. 5.6 Surface treatment techniques by dry and wet processes attempted in researches. Some of
them are commercialized
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In the stems of artificial hip joints and dental implants, the chemical bonding
of metal surfaces with bone is not expected. In other words, it is impossible for
metals as typical artificial materials to chemically and naturally bond with bone as
living tissue, especially in the human body with body fluid. Therefore, the surface
morphology is sometimes controlled, and rough and porous surface is formed in
titanium. Living tissue, such as bone, is expected to grow into the rough porous
surface, and the materials and bone are strongly connected as a result of the
so-called anchoring effect. Figure 5.7 shows chemical bonding and a mechanical
anchoring connection between bone and material.
5.6.4 Evolution of Surface Treatment for Bone Formation
Figure 5.8 shows the evolution of surface treatment techniques to improve hard
tissue compatibility at the research level:
First generation: Grind machining of the surface.
Second generation: Grooving, blast, acid etching, anodic oxidation, and laser
abrasion.
Third generation: Chemical treatment and hydroxyapatite coating.
Fourth generation: Immobilization of biofunctional molecules (collagen, bone
morphogenetic protein, and peptide).
Fifth generation: Coating of stem cells and tissues?
The bone formation of the materials surface is accelerated when biomolecules
concerning bone formation are immobilized on the material surface, such as in the
fourth generation in Fig. 5.8. Therefore, many studies have achieved good results in
this direction. However, to increase the popularity of the immobilization of
biofunctional molecules, it is necessary to ensure the safety, quality maintenance
during storage, and dry-conditioned durability of the immobilized layer. Therefore,
it is difficult for manufacturers to commercialize those research results. Most of
commercialized goods are categorized into the second generation, a few belong to
Material
Bone tissue
Bonding by ingrowth of bone
into porous material surface
Material
Chemical bonding
between bone and material
Bone tissue
a b
Fig. 5.7 Mechanical anchoring (a) and chemical bonding (b) between bone and material
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the third generation, and there is no prospect for the commercialization of the fourth
generation, at present. The commercialization went faster for the second than third
generation possibly because materials employing mechanical anchoring are more
practical than materials employing chemical bonding with bone.
On researches developing new surface treatment techniques, biocompatibility
and biofunction are usually focused, while sometimes mechanical properties,
durability, and manufacturing process are left behind, that may delays the utiliza-
tion of the technique. Most of researchers make the best effort to evaluate biological
effects with cell culture and animal test; they hesitate conduct the evaluation of
durability. They sometimes do not remember “materials engineering”, while
remind only materials chemistry and biological evaluation.
However, immobilization of biomolecules and biofunctional molecules as
shown as the fourth generation above is effective tool to add biofunction to metal
surface. This subject is reviewed somewhere [35].
5.7 Conclusions
Metallic materials are widely used in medicine not only for orthopedic implants and
dental implants, but also for cardiovascular devices and for other purposes. Metallic
biomaterials are always used in close contact with living tissues. Therefore,
interactions between material surfaces and living tissues must be well controlled.
Metal surface may be biofunctionalized by various surface treatment techniques.




































Fig. 5.8 The evolution of surface treatment techniques to improve hard tissue compatibility at the
research level
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